Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SNSS > SEC Filings for SNSS > Form 8-K on 9-Jun-2014All Recent SEC Filings

Show all filings for SUNESIS PHARMACEUTICALS INC

Form 8-K for SUNESIS PHARMACEUTICALS INC


9-Jun-2014

Submission of Matters to a Vote of Security Holders


Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2014 Annual Meeting of Stockholders, or the Annual Meeting, was held on June 5, 2014. Proxies for the Annual Meeting were solicited by the Board of Directors pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition to the Board of Directors' solicitation. There were 60,162,665 shares of common stock entitled to vote at the Annual Meeting. A total of 53,918,869 shares were represented at the Annual Meeting in person or by proxy. The final votes on the proposals presented at the meeting were as follows:

Proposal No. 1

Matthew K. Fust, David C. Stump and Daniel N. Swisher, Jr. were elected as Class
III directors to hold office until the 2017 Annual Meeting of Stockholders by
the following vote:



          Nominee                     For       Withheld   Broker Non-Votes
          Matthew K. Fust          44,226,299   146,544       9,546,026
          David C. Stump           44,225,299   147,544       9,546,026
          Daniel N. Swisher, Jr.   44,220,985   151,858       9,546,026

In addition to the directors elected above, Steve R. Carchedi, Helen S. Kim and Dayton Misfeldt will continue to serve as Class I directors until the 2015 Annual Meeting of Stockholders and until their successors are elected and have qualified, or until their earlier death, resignation or removal. James W. Young, Steven B. Ketchum and Homer L. Pearce will continue to serve as Class II directors until the 2016 Annual Meeting of Stockholders and until their successors are elected and have qualified, or until their earlier death, resignation or removal.

Proposal No. 2

The vote, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2014 proxy statement, filed with the Securities and Exchange Commission on April 24, 2014, was approved by the following vote:

For Against Abstain 44,179,177 129,275 64,391

Proposal No. 3

The selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2014 was ratified by the following vote:

For Against Abstain 53,794,678 111,954 12,237


  Add SNSS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SNSS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.